|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US3885035A
(en)
|
1972-04-05 |
1975-05-20 |
Sandoz Ag |
Method for treating arrhythmia by using 1,4-bis(4 quinazolinyl) piperazines
|
|
US3956495A
(en)
|
1973-10-30 |
1976-05-11 |
Eli Lilly And Company |
2,4-Diaminoquinazolines as antithrombotic agents
|
|
US3966936A
(en)
|
1974-02-21 |
1976-06-29 |
Pfizer Inc. |
Piperazino quinazoline bronchodilators
|
|
US4060615A
(en)
|
1976-02-18 |
1977-11-29 |
Mead Johnson & Company |
2-Piperazinyl-6,7-dimethoxyquinazolines
|
|
JPS562968A
(en)
|
1979-06-21 |
1981-01-13 |
Mitsubishi Yuka Yakuhin Kk |
Novel pyrimidine derivative
|
|
JPS6270A
(ja)
|
1985-03-07 |
1987-01-06 |
Sankyo Co Ltd |
シクロペンタ〔ｄ〕ピリミジン誘導体
|
|
US5583024A
(en)
|
1985-12-02 |
1996-12-10 |
The Regents Of The University Of California |
Recombinant expression of Coleoptera luciferase
|
|
US4959368A
(en)
|
1986-02-24 |
1990-09-25 |
Mitsui Petrochemical Industries Ltd. |
Therapeutic agent for neurological diseases
|
|
US4871739A
(en)
|
1987-01-21 |
1989-10-03 |
Merck & Co., Inc. |
Substituted 6H-7,8-dihydrothiapyrano(3,2-D)-pyrimidines as hyopglycemic agents
|
|
US4889856A
(en)
|
1987-08-31 |
1989-12-26 |
Merck & Co., Inc. |
7,8-dihydro-4-(1-pierazinyl)-6H-thiopyrano-[3,2-d] pyrimidines as β-blockers
|
|
US4994464A
(en)
|
1987-08-31 |
1991-02-19 |
Merck & Co., Inc. |
Piperazinylpyrimidines as β-adrenergic receptor blockers
|
|
MX19185A
(es)
|
1989-01-20 |
1993-12-01 |
Pfizer |
Procedimiento para preparar 3-(1,2,5,6-tretrahidropiridil)-pirrolopiridinas.
|
|
PT664291E
(pt)
|
1992-10-05 |
2000-11-30 |
Ube Industries |
Composto de pirimidina
|
|
US5750545A
(en)
|
1993-07-23 |
1998-05-12 |
The Green Cross Corporation |
Triazole derivative and pharmaceutical use thereof
|
|
GB9416189D0
(en)
|
1994-08-10 |
1994-09-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO1996005177A1
(en)
|
1994-08-13 |
1996-02-22 |
Yuhan Corporation |
Novel pyrimidine derivatives and processes for the preparation thereof
|
|
US5543523A
(en)
|
1994-11-15 |
1996-08-06 |
Regents Of The University Of Minnesota |
Method and intermediates for the synthesis of korupensamines
|
|
US5525625A
(en)
|
1995-01-24 |
1996-06-11 |
Warner-Lambert Company |
2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders
|
|
JPH08336393A
(ja)
|
1995-04-13 |
1996-12-24 |
Mitsubishi Chem Corp |
光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法
|
|
US7067664B1
(en)
|
1995-06-06 |
2006-06-27 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
ZA979961B
(en)
|
1996-11-15 |
1999-05-05 |
Lilly Co Eli |
5-HT1F agonists
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
US6310060B1
(en)
|
1998-06-24 |
2001-10-30 |
Warner-Lambert Company |
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
|
|
WO1999001426A1
(en)
|
1997-07-01 |
1999-01-14 |
Warner-Lambert Company |
4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
|
|
US6821963B2
(en)
|
1997-07-01 |
2004-11-23 |
Warner-Lambert Company |
4-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
|
|
NZ501277A
(en)
|
1997-07-01 |
2002-12-20 |
Warner Lambert Co |
-2(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
|
|
US6506798B1
(en)
|
1997-07-01 |
2003-01-14 |
Warner-Lambert Company |
4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors
|
|
US6602677B1
(en)
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
|
EP1067123B1
(en)
|
1998-03-31 |
2011-01-19 |
Kyowa Hakko Kirin Co., Ltd. |
Nitrogenous heterocyclic compounds
|
|
DE19853278A1
(de)
|
1998-11-19 |
2000-05-25 |
Aventis Pharma Gmbh |
Substituierte 4-Amino-2-aryl-cyclopenta[d]pyrimidine, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
JP2002534380A
(ja)
|
1999-01-07 |
2002-10-15 |
ワーナー−ランバート・カンパニー |
Ｍｅｋ阻害剤による喘息の治療
|
|
HUP0104933A3
(en)
|
1999-01-07 |
2003-12-29 |
Warner Lambert Co |
Antiviral method using mek inhibitors
|
|
EP1144385B1
(en)
|
1999-01-13 |
2005-08-17 |
Warner-Lambert Company Llc |
Benzoheterocycles and their use as mek inhibitors
|
|
CA2349832A1
(en)
|
1999-01-13 |
2000-07-20 |
Warner-Lambert Company |
Benzenesulfonamide derivatives and their use as mek inhibitors
|
|
EE200100374A
(et)
|
1999-01-13 |
2002-12-16 |
Warner-Lambert Company |
1-heterotsükliga asendatud diarüülamiinid
|
|
CA2348236A1
(en)
|
1999-01-13 |
2000-07-20 |
Stephen Douglas Barrett |
4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
|
|
JP2002534446A
(ja)
|
1999-01-13 |
2002-10-15 |
ワーナー−ランバート・カンパニー |
４′ヘテロアリールジアリールアミン
|
|
WO2000042002A1
(en)
|
1999-01-13 |
2000-07-20 |
Warner-Lambert Company |
Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
|
|
GB9910577D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
WO2001005390A2
(en)
|
1999-07-16 |
2001-01-25 |
Warner-Lambert Company |
Method for treating chronic pain using mek inhibitors
|
|
HUP0202623A3
(en)
|
1999-07-16 |
2003-03-28 |
Warner Lambert Co |
Method for treating chronic pain using mek inhibitors
|
|
AU5912500A
(en)
|
1999-07-16 |
2001-02-05 |
Warner-Lambert Company |
Method for treating chronic pain using mek inhibitors
|
|
CN1358095A
(zh)
|
1999-07-16 |
2002-07-10 |
沃尼尔·朗伯公司 |
使用mek抑制剂治疗慢性疼痛的方法
|
|
MXPA02008103A
(es)
|
2000-03-15 |
2002-11-29 |
Warner Lambert Co |
Diarilaminas sustituidas con 5-amida como inhibidores mek.
|
|
OA12333A
(en)
|
2000-07-19 |
2004-04-06 |
Warner Lambert Co |
Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids.
|
|
AP2001002249A0
(en)
|
2000-08-25 |
2001-09-30 |
Warner Lambert Co |
Process for making N-ARYL-ANTHRANILIC acids and their derivatives.
|
|
CA2422367C
(en)
|
2000-09-15 |
2010-05-18 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
EP1337524A1
(en)
|
2000-11-02 |
2003-08-27 |
AstraZeneca AB |
Substituted quinolines as antitumor agents
|
|
WO2002083139A1
(en)
|
2001-04-10 |
2002-10-24 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
|
MXPA03009938A
(es)
|
2001-04-30 |
2005-09-07 |
Glaxo Group Ltd |
Pirimidinas fusionadas como antagonistas del factor liberador de corticotropina.
|
|
AU2002336462A1
(en)
|
2001-09-06 |
2003-03-24 |
Millennium Pharmaceuticals, Inc. |
Piperazine and homopiperazine compounds
|
|
ATE424388T1
(de)
|
2001-12-06 |
2009-03-15 |
Merck & Co Inc |
Mitotische kinesinhemmer
|
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
|
CA2473510A1
(en)
|
2002-01-23 |
2003-07-31 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives as rho-kinase inhibitors
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
US7235537B2
(en)
|
2002-03-13 |
2007-06-26 |
Array Biopharma, Inc. |
N3 alkylated benzimidazole derivatives as MEK inhibitors
|
|
AU2003220202A1
(en)
|
2002-03-13 |
2003-09-29 |
Array Biopharma, Inc |
N3 alkylated benzimidazole derivatives as mek inhibitors
|
|
PT1482932E
(pt)
|
2002-03-13 |
2010-01-12 |
Array Biopharma Inc |
Derivados de benzimidazole alquilado n3 como inibidores de mek
|
|
AU2003230802B2
(en)
|
2002-04-08 |
2007-08-09 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
|
EP1496896A4
(en)
|
2002-04-08 |
2007-10-31 |
Merck & Co Inc |
AKT INHIBITORS EFFECT
|
|
US7273869B2
(en)
|
2002-04-08 |
2007-09-25 |
Merck & Co., Inc. |
Inhibitors of Akt activity
|
|
WO2003086279A2
(en)
|
2002-04-08 |
2003-10-23 |
Merck & Co., Inc. |
Inhibitors of akt activity
|
|
CA2484968A1
(en)
|
2002-05-10 |
2003-11-20 |
Neurocrine Biosciences, Inc. |
Substituted piperazine as melanocortin receptors ligands
|
|
AU2003284981B2
(en)
|
2002-10-30 |
2009-05-28 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
|
US20040102360A1
(en)
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
|
MXPA05005547A
(es)
|
2002-11-28 |
2005-07-26 |
Schering Ag |
Pirimidinas inhibidoras de chk, pdk y akt, su produccion y uso como agentes farmaceuticos.
|
|
GB0308208D0
(en)
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
|
JP2006524254A
(ja)
|
2003-04-24 |
2006-10-26 |
メルク エンド カムパニー インコーポレーテッド |
Ａｋｔ活性の阻害剤
|
|
EP1646615B1
(en)
|
2003-06-06 |
2009-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
|
EP1663994B1
(en)
|
2003-08-05 |
2012-03-07 |
Vertex Pharmaceuticals Incorporated |
Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
|
|
WO2005014557A1
(en)
|
2003-08-12 |
2005-02-17 |
F.Hoffmann-La Roche Ag |
Tetrahydroquinazoline derivatives as cfr antagonists
|
|
CA2538026A1
(en)
|
2003-09-09 |
2005-03-24 |
Ono Pharmaceutical Co., Ltd. |
Crf antagonists and heterobicyclic compounds
|
|
US20050182061A1
(en)
|
2003-10-02 |
2005-08-18 |
Jeremy Green |
Phthalimide compounds useful as protein kinase inhibitors
|
|
JP2007509125A
(ja)
*
|
2003-10-21 |
2007-04-12 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
Ｎ−〔（ｒ）−２，３−ジヒドロキシ−プロポキシ〕−３，４−ジフルオロ−２−（２−フルオロ−４−ヨード−フェニルアミノ）−ベンズアミドの多形
|
|
BRPI0416852A
(pt)
|
2003-11-21 |
2007-02-27 |
Array Biopharma Inc |
inibidores da quinase akt
|
|
WO2005117909A2
(en)
|
2004-04-23 |
2005-12-15 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
|
DE602005020611D1
(de)
|
2004-04-28 |
2010-05-27 |
Vertex Pharma |
Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
|
|
KR20070027723A
(ko)
|
2004-06-28 |
2007-03-09 |
알타나 파마 아게 |
4,6-이치환된 피리미딘 및 단백질 키나제 억제제로서의이의 용도
|
|
US20060025074A1
(en)
|
2004-07-30 |
2006-02-02 |
Chih-Ming Liang |
Bluetooth-based headset
|
|
TWM266655U
(en)
|
2004-09-23 |
2005-06-01 |
Blueexpert Technology Corp |
Bluetooth earphone device capable of wirelessly receiving and transmitting stereo sound signal and digital information signal
|
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
|
|
WO2006071819A1
(en)
|
2004-12-28 |
2006-07-06 |
Exelixis, Inc. |
[1h-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
|
|
JP2008531542A
(ja)
|
2005-02-24 |
2008-08-14 |
ファイザー・プロダクツ・インク |
抗癌剤として有用な二環式複素芳香族誘導体
|
|
EP1866822A4
(en)
|
2005-03-03 |
2010-09-01 |
Burnham Inst Medical Research |
SCREENING PROCEDURE FOR PROTEIN KINASE B INHIBITORS USING VIRTUAL DOCKING APPARATUS AND COMPOSITIONS AND COMPOSITIONS DISCOVERED THEREFOR
|
|
KR20080016659A
(ko)
|
2005-05-20 |
2008-02-21 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제의 억제제로서 유용한 피롤로피리딘
|
|
AR054485A1
(es)
|
2005-06-21 |
2007-06-27 |
Cancer Rec Tech Ltd |
ARIL-ALQUILAMINAS Y HETEROARIL-ALQUILAMINAS COMO INHIBIDORES DE PROTEINA QUINASA A Y B, UN PROCESO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN Y SU USO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO O PROFILAXIS DE ENFERMEDADES ORIGINADAS EN EL CRECIMIENTO ANORMAL DE LA
|
|
AU2006302415B2
(en)
|
2005-10-07 |
2012-09-13 |
Exelixis, Inc. |
Azetidines as MEK inhibitors for the treatment of proliferative diseases
|
|
BRPI0617241A2
(pt)
|
2005-10-13 |
2016-11-08 |
Glaxo Group Ltd |
composto ou um sal ou solvato do mesmo, composição farmacêutica, método para tratar uma doença ou condição mediada por atividade syk inadequada em um mamífero, e, uso de um composto ou um sal ou solvato farmaceuticamente aceitável do mesmo
|
|
AR056893A1
(es)
|
2005-12-28 |
2007-10-31 |
Takeda Pharmaceutical |
Compuestos heterociclicos fusionados y no fusionados, antagonistas de receptores mineralocorticoides
|
|
JP2009534454A
(ja)
|
2006-04-25 |
2009-09-24 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
RU2008152171A
(ru)
|
2006-07-05 |
2010-08-10 |
Интермьюн, Инк. (Us) |
Новые ингибиторы вирусной репликации гепатита с
|
|
DK2054418T3
(da)
|
2006-07-06 |
2012-02-27 |
Array Biopharma Inc |
Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer
|
|
ES2385505T3
(es)
|
2006-07-06 |
2012-07-25 |
Glaxo Group Limited |
N-fenilmetil-5-oxo-prolina-2-amidas sustituidas como antagonistas del receptor P2X7 y métodos de uso
|
|
TW200808325A
(en)
|
2006-07-06 |
2008-02-16 |
Astrazeneca Ab |
Novel compounds
|
|
GB0613518D0
(en)
|
2006-07-06 |
2006-08-16 |
Phytopharm Plc |
Chemical compounds
|
|
UA95641C2
(xx)
*
|
2006-07-06 |
2011-08-25 |
Эррей Биофарма Инк. |
Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
|
|
US8063050B2
(en)
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
SI2049500T1
(sl)
|
2006-07-06 |
2012-01-31 |
Array Biopharma Inc |
Ciklopenta (d) pirimidini kot AKT protein kinazni inhibitorji
|
|
US7910747B2
(en)
|
2006-07-06 |
2011-03-22 |
Bristol-Myers Squibb Company |
Phosphonate and phosphinate pyrazolylamide glucokinase activators
|
|
WO2008012635A2
(en)
|
2006-07-26 |
2008-01-31 |
Pfizer Products Inc. |
Amine derivatives useful as anticancer agents
|
|
CN105106199A
(zh)
*
|
2006-12-14 |
2015-12-02 |
埃克塞利希斯股份有限公司 |
使用mek抑制剂的方法
|
|
US8247397B2
(en)
*
|
2007-09-12 |
2012-08-21 |
Genentech, Inc. |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
|
|
BRPI0915901A2
(pt)
*
|
2008-07-11 |
2015-10-27 |
Novartis Ag |
combinação de (a) um inibidor de fosfoinositídeo 3-quinase e (b) um modulador da via ras/raf/mek
|
|
WO2010014939A1
(en)
|
2008-07-31 |
2010-02-04 |
Genentech, Inc. |
Pyrimidine compounds, compositions and methods of use
|
|
KR20120099219A
(ko)
*
|
2009-09-23 |
2012-09-07 |
글락소스미스클라인 엘엘씨 |
조합물
|